Omega Funds operates as a Boston-based venture capital investment firm focused on early-stage life sciences and healthcare opportunities in North America and Western Europe. It backs companies across biotechnology, pharmaceuticals, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and SaaS, and manages multiple venture funds including Omega Fund IV, V, VI, and VII. With offices in Boston and Geneva, Omega Funds collaborates with researchers and entrepreneurs to advance medical innovations and bring new therapies and products to patients, pursuing value through strategic support, potential exits, and long-term partnerships.

The European Innovation Council is a European Commission initiative that supports Europe’s deep-tech innovators, researchers, and startups. It funds breakthrough research and technology transfer projects, and delivers equity-like investments through the EIC Fund, as well as prizes and acceleration services to help teams scale. The council also co-invests with private investors in early-stage ventures and places emphasis on high-impact technologies with ESG relevance. Established in 2018 and headquartered in Brussels, it concentrates on deep-tech sectors including defence and dual-use technologies, while promoting international collaboration and market access for awardees. It aims to strengthen Europe’s innovation ecosystem by sharing data, hosting events, publishing insights, and fostering partnerships that accelerate the journey from lab to market.

Alpana Ventures is a Swiss venture capital firm focused on digital transformation and deep-tech across Switzerland, Europe and the United States. Based in Geneva, it backs founder teams at seed, early stage and growth phases, with the aim of embedding innovative technologies into scalable business models to create lasting value and global market leadership. The firm emphasizes ESG criteria in its investment approach and spans sectors including healthcare, information technology, finance, enterprise software, mobility, cybersecurity, gaming and data-intensive applications.

4See Ventures is a Swiss venture capital firm based in Geneva that backs early-stage startups in healthcare, biotech, medtech, technology, sustainability and climate tech. Founded in 2019, the firm concentrates on Swiss ventures with game-changing potential, emphasizing disruptive innovation, market insight, and anticipation of future trends. It supports entrepreneurs who drive societal impact and transformation, and has invested in companies such as Haya Therapeutics, Transmutex, Distalmotion, and Goodwall.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Alta Berkeley is a London-based venture capital firm founded in 1982 that specializes in early-stage technology investments across Europe, Israel and the United States. The firm backs seed and startup opportunities with a focus on high-technology sectors including software, semiconductor, communication and computing technologies, and medical technology. It typically invests in initial rounds around 1.5 to 3 million pounds and increases to roughly 4 to 8 million as companies advance, often taking a lead role while also co-investing in syndicates. The firm supports portfolio companies through growth and strategic development with an emphasis on helping early-stage ventures scale. Exits are pursued through public offerings, acquisitions or trade sales in the United States and Europe. Alta Berkeley maintains a London headquarters and has had an additional office in Geneva, reflecting a cross-border approach to backing technology ventures. The firm seeks to build value by combining operational guidance with sector expertise to help portfolio companies mature toward scalable commercial success.

Tayssir Capital is a Geneva-based venture capital firm, established in 2021, that specializes in digital assets investments. The company focuses on identifying and funding opportunities in the digital asset space from its Geneva base, aiming to support early-stage and growth ventures with capital and strategic guidance.

Climb Ventures is a Swiss venture capital firm founded in 2020 and based in Geneva. It backs technology-focused startups across Europe, investing in sectors such as information technology, IoT, advanced manufacturing, fintech, AR, clean tech, e-commerce, gaming, and agtech, with particular attention to Swiss companies pursuing global scale. The firm provides capital, strategic guidance, and access to industry networks to accelerate growth and international expansion, including AI, renewable energy, and digital transformation. Climb targets founders with global ambitions and supports growth to late-stage across digital services, consumer internet, and emerging technologies, leveraging a European footprint to drive market penetration.

VI Partners is a Swiss venture capital firm founded in 2001 and based in Altendorf, focused on investments in healthcare and technology companies across Switzerland and Europe. The firm backs university spin-offs and other start-ups by providing capital, coaching and networks, and it participates in seed and Series A financing to help innovative companies scale. With a long track record in the Swiss and European markets, VI Partners supports high-growth healthcare, biotechnology, technology and software ventures through early and growth stages, drawing on sector expertise and hands-on engagement.

DART Ventures is a Zurich-based venture capital firm that backs early-stage startups in health and climate technologies across the United States and Europe. It invests in B2B, health technology, health consumer tech, food tech, clean tech, and climate tech ventures, with a focus on patient-centric AI, decarbonization, and energy transition. The firm runs a 12-month tailored expansion program that provides strategic guidance on growth, culture, fundraising, and go-to-market, leveraging experienced partners and networks to help portfolio companies expand in the US. DART Ventures emphasizes founder alignment of purpose and profit and seeks to connect portfolio companies with US investors and board members to support scale.

CDP Venture Capital is the leading Italian venture capital fund manager overseeing about €4.9 billion in assets under management across 15 direct and indirect funds. It supports innovation and sustainable value creation in sectors strategic to Italy’s growth, guided by governance, sustainability, and ethics. The firm backs a broad portfolio of companies and provides pathways to involvement through its networks and reporting. Based in Rome and Milan, it pursues investments across Italy, including seed-stage and growth opportunities, with emphasis on areas such as artificial intelligence, cybersecurity, agrifood technology, clean technology, space technology, healthcare and life science, industry technology, and mobility. The manager focuses on creating favorable conditions for the venture capital ecosystem and broader Italian economic development while promoting responsible investment in innovation.

Syncona is a London-based venture capital firm founded in 2012 that invests in healthcare and life sciences companies. The firm seeks to build and scale global leaders in the field, with a focus on innovative therapies and the advancement of biomedical science. It pursues a long-term investment approach, supporting portfolio companies across early to established stages and collaborating with scientific founders to translate research into commercial medicines. Through its emphasis on durable value creation in life sciences, Syncona aims to contribute to meaningful patient impact while developing a diversified portfolio of leading companies.

Gaingels is a global venture investment syndicate focused on supporting LGBTQ-founded and led companies and advancing inclusive leadership across stages from early to growth. Founded in 2014 and based in New York, it maintains a portfolio of 130+ companies and about $70 million deployed, and it co-invests with other venture capital partners. Beyond capital, Gaingels assists portfolio firms in recruiting diverse talent for C-suite and board roles and fosters a worldwide community of investors, operators, and entrepreneurs dedicated to positive social change through business.

Amboy Street Ventures is a venture capital firm that concentrates on women’s health and sexual wellbeing startups. Founded in 2021 and based in Los Angeles, the firm focuses on early-stage investments, including seed and Series A rounds, with a geographic scope spanning the United States and Europe. It backs companies developing fertility, sexual health, and broader women’s health technologies across multiple sub-segments, such as menopause, maternal health, LGBTQ+ health, menstrual health, hormonal health, and sexual wellness. Portfolio areas include products and services ranging from vaginal microbiome testing and male contraception to at‑home insemination kits, digital abortion care, and telehealth services. The firm positions itself to support innovative startups addressing unmet needs in women’s health and sexual wellbeing, aiming to advance access and care for diverse populations.

OCCIDENT is a Munich-based venture capital firm that targets deep-tech startups with spin-offs from scientific research to deliver real-world impact. As an owner-managed investor with offices in Munich and Zug, it funds its own capital and supports portfolio companies from the seed stage onward, providing long-term financial backing and hands-on expertise. The firm concentrates on life sciences and industrial technology, aiming for sustainable value and tangible societal benefits, guided by a science-driven ethos. With a portfolio of active companies and a track record of notable milestones, including successful exits and growth milestones, OCCIDENT works closely with founding teams to advance scientifically driven ventures from concept to impact.

LIFTT is a Europe-based venture capital holding focused on deep-tech investing across multiple verticals to create measurable impact. The firm maintains an operational, hands-on approach and supports the translation of scientific research into high-impact enterprises, accelerating the journey from lab to market. Its multi-vertical investment strategy targets Critical Resources, Human Health & Aging, Infrastructure for Data Revolution, and Energy Security & Industrial Automation, and it operates across Europe with a global vision. Based in Turin at OGR Tech and led by President Stefano Buono, LIFTT connects ideas, talent, territories and financial resources to foster innovation and local impact.

Panakes Partners is an independent venture capital firm based in Milan, Italy, that backs early-stage life sciences and technology companies across Europe and Israel. Founded in 2015, the firm seeks ambitious teams developing innovative healthcare technologies and products. It provides financial support and strategic guidance through a network of clinicians and industry experts to accelerate portfolio development and address unmet medical needs. Panakes emphasizes strong teams and impactful offerings, and integrates environmental, social, and governance considerations into its investment process, aligning with UN PRI principles. The firm also collaborates with EU programs such as Horizon 2020 and COSME via INNOVFIN to support portfolio companies' growth.

Velocity Ventures is a venture capital firm focused on the global travel and hospitality sector, investing in seed to Series A startups spanning travel services, transportation, accommodation, experiences, and food and beverage. With a team of travel and hospitality specialists and entrepreneurs, the firm combines over 130 years of operating and investing experience and operates with a hands-on, value-added approach. It engages across APAC and globally, leveraging a network that includes governments, accelerators, and corporate partners to support portfolio growth. The firm seeks visionary founders and shares industry insights through reports and outlooks to help shape the future of travel and hospitality.

Innovationsstiftung der SZKB is a venture capital investor established in 2006 and based in Schwyz, Switzerland. It finances early-stage technology companies across Switzerland, focusing on software, SaaS, enterprise, and consumer software sectors. It has supported Swiss startups as a lead investor in first-round financings and has a reported capital base of CHF 20 million. The entity operates with investment decisions that are independent of SZKB while maintaining ties to the group, and concentrates on helping young technology companies achieve growth in the Swiss market.

Spicehaus Partners is an independent Swiss venture capital investor focused on early-stage technology companies in Switzerland. Based in Zug, it leads investments in B2B software and provides active support to portfolio companies to drive growth, with a portfolio of over 40 funded companies and exits such as MOVU and Bexio. Its investments span fintech, proptech, big data, robotics, and cybersecurity, and it aims to foster innovation and job creation in Switzerland’s tech sector through long-term partnerships and hands-on involvement. The firm operates the Spicehaus Swiss Venture Fund, launched in 2019, to support the international expansion of Swiss technology companies.

Next Ventures is a venture capital firm with a global presence that invests in early- and growth-stage companies across health, wellness, sports, fitness, and technology sectors. The firm backs opportunities in fintech, software, and other tech-enabled markets, drawing on sector expertise to support portfolio companies beyond financing. With activity in multiple regions, Next Ventures seeks to partner with entrepreneurs aiming to transform health outcomes, athletic performance, and consumer technology, delivering value through strategic guidance, network access, and operational insight.

ACE & Company is a global private equity and venture capital firm based in Geneva, Switzerland, with offices in Zurich, New York, London, and Cairo. Founded in 2005, the firm operates through ACE Ventures, its venture capital arm focused on early to late-stage technology companies, and ACE Private Equity, which concentrates on lower mid-market buyouts and secondary investments. ACE offers three core investment strategies across stages—secondaries, buyout, and venture—driving returns through diversified exposure and risk management. The firm is sector and region agnostic, investing across a broad range of industries and geographies, and has built a global investor experience with a hands-on governance framework and investment committees. It has more than $2 billion in assets under management and pursues global private market opportunities with a focus on long-term sustainable results.

LGT Capital Partners is a Swiss-based alternative investment manager, headquartered in Pfäffikon with a Zurich base and offices globally, that focuses on private markets and multi-asset solutions. It offers investments across private equity, real estate, hedge funds, and private credit, including buyouts, venture capital, growth finance, mezzanine financing, and special situations, alongside liquid alternatives and multi-strategy approaches. The firm serves institutional clients such as pension funds, sovereign wealth funds, insurers, foundations, endowments and banks worldwide, and employs a rigorous, bottom-up investment process to select managers and opportunities across public and private markets.

TeleSoft Partners is a venture capital firm founded in 1996 and based in Aspen, Colorado, focused on technology and energy value chain companies in North America. It provides capital alongside strategic guidance, leveraging its knowledge, contacts, and operational experience to help entrepreneurs grow. The firm backs companies across early to later stages and has a track record of supporting portfolio companies through acquisitions and initial public offerings, particularly in software and technology, media and telecommunications sectors.

Paradigm is a venture capital firm based in San Francisco that invests in and builds with founders across crypto, artificial intelligence, robotics, and other emerging technologies. Founded in 2018, the firm provides capital, technical research support, and strategic guidance throughout multiple growth stages, working with teams on product development, operations, and open-source initiatives. Paradigm emphasizes hands-on collaboration, backing category-defining protocols and projects at the frontier of how people transact, build, and compute. With a global reach and a focus on early to late-stage opportunities, the firm seeks to advance technological frontiers by combining research with practical execution alongside the builders shaping the future.

Section 32 is a venture capital investment firm founded in 2017 by Bill Maris and headquartered in Silicon Valley. It concentrates on early-stage and high-potential technology, life sciences, and healthcare companies across the United States, with a focus on frontiers of technology such as artificial intelligence, computational biology, data, cybersecurity, quantum computing, and enterprise software. The firm emphasizes deep, hands-on support, leveraging a small, experienced team to back a selective portfolio and help with hiring and go-to-market efforts. Section 32 aims to back obsessive founders building iconic companies and foster technologies that advance the human condition.

Nauta Capital is a European venture capital firm focused on early-stage B2B software companies. Based in London with offices in Barcelona and Munich, it funds Series A, late seed, and Series B rounds across Europe. The firm targets B2B software with strong network effects, enterprise technology that transforms large industries, and AI/ML applications, and it supports portfolio companies across sectors such as retail tech, revenue tech, fintech, and health tech. Nauta provides capital and strategic guidance to help founders scale and achieve exits.

TNF Capital is an international private equity and venture capital firm based in Geneva, Switzerland, with additional offices in Dubai and Hong Kong. The firm focuses on various stages of investment, including seed capital, early-stage, mid-stage, late-stage, growth capital, and private equity buy-outs. TNF Capital is sector agnostic but has a particular emphasis on technology, financial market infrastructure, real-time communications, cybersecurity, and commodity trading. It typically seeks to take majority stakes in its investments and operates both independently and as a co-investor. Established over a decade ago by Erkin Bek, the firm aims to unlock entrepreneurial and disruptive potential by providing capital, connections, and expertise to drive growth and innovation across its portfolio.

TPY Capital is a Tel Aviv-based early-stage venture capital firm that invests in Israeli technology startups. It typically leads rounds in sectors such as data and analytics, enterprise digitization, cloud infrastructure, human augmentation, fintech, and frontier technologies including quantum computing. The firm supports portfolio companies with strategic guidance and hands-on execution help, acting as an active partner to foster growth across early, pre-revenue, revenue-stage, and growth-stage investments. TPY Capital focuses on technology-driven companies and prefers minority positions. Founded in 2011, TPY Capital operates from Tel Aviv and concentrates on Israeli ventures.

Nyca Partners is a fintech-focused venture capital and advisory firm founded in 2014 and headquartered in New York. It invests in early-stage financial technology companies across the United States, offering strategic support and access to a broad network of financial institutions, technology partners, and advisors to help portfolio companies grow. The firm emphasizes a collaborative approach that combines investment expertise with operational insight and pursues thematic investing across four verticals: payments and financial transactions, capital formation and risk, digital advice, and financial infrastructure, all aimed at modernizing the financial system. Its portfolio comprises approximately 975 million dollars in assets under management and 88 active investments, including unicorns.

Valuta Capital Partners is a global advisory and investment firm headquartered in Istanbul, established in 2005. It provides management consulting and investment solutions to businesses and families, with a Dubai presence. The firm supports SMEs and startups through direct investments and co-investments, as well as pre-deal financial advisory, M&A support, financing solutions, and wealth preservation guidance. Drawing on a network of international investors and service providers, Valuta Capital Partners emphasizes strategic know-how, disciplined project management, and long-term partnerships, aiming to understand each client's needs and deliver sustainable value. The organization prioritizes industry expertise and a personal touch, supported by an external advisory board of industry leaders.

Phystech Ventures is a London-based venture capital firm focusing on early-stage deeptech companies worldwide. Founded in 2013, it concentrates on seed and Series A rounds and often serves as the first institutional investor in its portfolio companies. The firm has backed 31 companies across nine countries, including spin-offs from eight universities, and seeks to support ventures that leverage fundamental scientific advances to deliver transformative solutions across industries.

ProQuest Investments is a healthcare venture capital firm founded in 1998 that provides seed to late-stage financing to healthcare and biotechnology companies. The firm manages over $875 million in capital and operates offices in Princeton, San Diego, and Montreal. It has a focus on therapeutics and has investments across oncology, pain, and infectious disease, seeking long-term partnerships with entrepreneurs.

Global Finance is an independent investment firm founded in 1991 in Athens, Greece, specializing in private equity and venture capital in Southeast Europe. The firm conducts private equity fund management, real estate development, and advisory services, and makes equity investments in the region. It typically targets opportunities in Greece and other Eastern European markets, with investment sizes up to €40 million in Greece and up to €15 million for Eastern European ventures. Global Finance operates a regional footprint with offices in Athens and major regional hubs such as Sofia, Belgrade, Bucharest, and London, enabling it to source deals and support portfolio companies across Southeastern Europe. The firm focuses on growth-oriented opportunities, including management buyouts and growth capital, and aims to create value through active portfolio management and strategic exits.